ATTENZIONE IBDOLOGI! LA RESEZIONE ILEOCECALE PER IL MORBO DI CROHN POTREBBE AVERE UN RUOLO COME PRIMA TERAPIA RISPETTO AGLI ANTI-TNF! LO STUDIO PREDICT SU POPOLAZIONE DA “GASTROENTEROLOGY” (FREE).
Early Ileocecal Resection for Crohn’s Disease Is Associated With Improved Long-term Outcomes Compared With Anti-Tumor Necrosis Factor Therapy: A Population-Based Cohort Study Manasi Agrawal et al. Background & Aims Early Crohn’s disease (CD) treatment involves anti-tumor necrosis factor (TNF) agents, whereas ileocecal resection (ICR) is reserved for complicated CD or treatment failure. We compared long-term…